Monopar Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25k | 300 | 81.67 |
| 2025-06-30 | $15k | 415 | 35.78 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors